CD274 and neoplasm: Thus, the combination of inhibitors targeting exosome secretion with anti-PD-L1 blockade targeting cell-surface PD-L1 may be a promising strategy to effectively suppress tumor growth in the clinic (Yang et al., 2018; Poggio et al., 2019).